全部

1·No additional immunosuppressive therapy was applied.

然后不进行其他的免疫抑制治疗。

2·AIM To explore the immunosuppressive therapy for post liver transplantation.

目的探讨肝移植术后的免疫抑制疗法。

3·Objective To study immunosuppressive therapy after multiple organ transplantation.

目的探讨多器官联合移植术后的免疫抑制治疗方法。

4·After withdrawal of immunosuppressive therapy, no recurrence of the lymphoma was seen.

在撤出之后的免疫抑制治疗，无复发的淋巴瘤，看到。

5·A cholinesterase inhibitor (ChEI) and immunosuppressive therapy were applied for treatment.

一种胆碱酯酶抑制剂和免疫抑制疗法用于治疗。

6·This patient's inflammatory arthritis required that she receive immunosuppressive therapy to control her symptoms.

这例病人的炎性关节炎要求她接受免疫抑制剂治疗，以控制其症状。

7·This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy.

这个发现可能有助于确定能安全地减少或停止使用免疫抑制疗法的其他移植受者。

8·Objective To evaluate the long term outcome of immunosuppressive therapy (IST) in patients with severe aplastic anemia (SAA).

目的评价重型再生障碍性贫血(SAA)患者免疫抑制治疗(ist)后的远期疗效。

9·Objective: to explore the feasibility, efficacy, and safety of high-dose immunosuppressive therapy in patients with autoimmune diseases.

目的：探讨大剂量化疗治疗自身免疫性疾病的可行性、疗效以及安全性。

10·Following a kidney transplant, recipients must be placed on immunosuppressive therapy or their immune systems will reject the transplanted organ.

在肾移植后，受者必须接受免疫抑制治疗，否则他们的免疫系统将排斥移植器官。